Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

IOVAIOVA
Showing 8 of 24 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in IOVANCE BIOTHERAPEUTICS INC

MetLife Investment Management, LLC holds 232,151 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), worth $965,748 as of 2026-Q2. The position was increased (+25.9% shares). IOVA represents 0.0% of MetLife Investment Management, LLC's portfolio.

Current Value

$965,748

Current Shares

232,151

Total Value Change

-$409,098

Total Shares Change

+85,735

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
232,151
+25.9%
$965,7480.0%$4.16
31
2026-Q1
Increased
184,399
+8.0%
$647,2400.0%$3.74
26
2025-Q4
Increased
170,782
+20.5%
$466,2350.0%$2.77
29
2025-Q3
Decreased
141,686
-6.2%
$307,4590.0%$2.23
0
2025-Q2
Decreased
150,974
-0.1%
$259,6740.0%$1.69
0
2025-Q1
Decreased
151,206
-8.8%
$503,5160.0%$3.56
0
2024-Q4
Increased
165,842
+13.3%
$1.2M0.0%$7.17
29
2024-Q3
Unchanged
146,416
0.0%
$1.4M0.0%$9.61
0

Other major holders of IOVA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used